These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24454895)

  • 1. A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity.
    Leigh ND; Bian G; Ding X; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
    PLoS One; 2014; 9(1):e85587. PubMed ID: 24454895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.
    Ding X; Bian G; Leigh ND; Qiu J; McCarthy PL; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
    J Immunol; 2012 Nov; 189(10):4719-27. PubMed ID: 23045613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.
    Burdelya LG; Brackett CM; Kojouharov B; Gitlin II; Leonova KI; Gleiberman AS; Aygun-Sunar S; Veith J; Johnson C; Haderski GJ; Stanhope-Baker P; Allamaneni S; Skitzki J; Zeng M; Martsen E; Medvedev A; Scheblyakov D; Artemicheva NM; Logunov DY; Gintsburg AL; Naroditsky BS; Makarov SS; Gudkov AV
    Proc Natl Acad Sci U S A; 2013 May; 110(20):E1857-66. PubMed ID: 23630282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.
    Hossain MS; Ramachandiran S; Gewirtz AT; Waller EK
    PLoS One; 2014; 9(5):e96165. PubMed ID: 24879439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy.
    Burdelya LG; Gleiberman AS; Toshkov I; Aygun-Sunar S; Bapardekar M; Manderscheid-Kern P; Bellnier D; Krivokrysenko VI; Feinstein E; Gudkov AV
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):228-34. PubMed ID: 22000579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.
    Mett V; Komarova EA; Greene K; Bespalov I; Brackett C; Gillard B; Gleiberman AS; Toshkov IA; Aygün-Sunar S; Johnson C; Karasik E; Bapardekar-Nair M; Kurnasov OV; Osterman AL; Stanhope-Baker PS; Morrison C; Moser MT; Foster BA; Gudkov AV
    Oncogene; 2018 Jan; 37(4):439-449. PubMed ID: 28967901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBLB502, a Toll-like receptor 5 agonist, offers protection against radiation-induced male reproductive system damage in mice.
    Bai H; Sun F; Yang G; Wang L; Zhang Q; Zhang Q; Zhan Y; Chen J; Yu M; Li C; Yin R; Yang X; Ge C
    Biol Reprod; 2019 Jan; 100(1):281-291. PubMed ID: 30084935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 5 agonist CBLB502 induces radioprotective effects in vitro.
    Shi T; Li L; Zhou G; Wang C; Chen X; Zhang R; Xu J; Lu X; Jiang H; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):487-495. PubMed ID: 28407032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of TRIF protein in regulating the proliferation and antigen presentation ability of myeloid dendritic cells through the ERK1/2 signaling pathway in chronic low-grade inflammation of intestinal mucosa mediated by flagellin-TLR5 complex signal.
    Zhuang Z; Chen Y; Zheng J; Chen S
    PeerJ; 2024; 12():e16716. PubMed ID: 38188180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRC4 Mutation in flagellin-derived peptide CBLB502 ligand-binding domain reduces the inflammatory response but not radioprotective activity.
    Lai L; Yang G; Yao X; Wang L; Zhan Y; Yu M; Yin R; Li C; Yang X; Ge C
    J Radiat Res; 2019 Nov; 60(6):780-785. PubMed ID: 31599956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism.
    Yang H; Brackett CM; Morales-Tirado VM; Li Z; Zhang Q; Wilson MW; Benjamin C; Harris W; Waller EK; Gudkov AV; Burdelya LG; Grossniklaus HE
    Oncotarget; 2016 Jan; 7(3):2936-50. PubMed ID: 26655090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy.
    Gonzalez C; Williamson S; Gammon ST; Glazer S; Rhee JH; Piwnica-Worms D
    Commun Biol; 2023 Jan; 6(1):31. PubMed ID: 36635337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBLB502, an agonist of Toll-like receptor 5, has antioxidant and scavenging free radicals activities in vitro.
    Li W; Ge C; Yang L; Wang R; Lu Y; Gao Y; Li Z; Wu Y; Zheng X; Wang Z; Zhang C
    Int J Biol Macromol; 2016 Jan; 82():97-103. PubMed ID: 26476243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
    Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
    Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models.
    Burdelya LG; Krivokrysenko VI; Tallant TC; Strom E; Gleiberman AS; Gupta D; Kurnasov OV; Fort FL; Osterman AL; Didonato JA; Feinstein E; Gudkov AV
    Science; 2008 Apr; 320(5873):226-30. PubMed ID: 18403709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation.
    McCarron M; Reen DJ
    J Immunol; 2009 Jan; 182(1):55-62. PubMed ID: 19109135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice.
    Wang Q; Duan J; Hong J; Ding K; Tai F; Zhu J; Fu H; Zheng X; Ge C
    In Vivo; 2024; 38(4):1636-1648. PubMed ID: 38936936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect Toll-like receptor 5-mediated activation of conventional dendritic cells promotes the mucosal adjuvant activity of flagellin in the respiratory tract.
    Fougeron D; Van Maele L; Songhet P; Cayet D; Hot D; Van Rooijen N; Mollenkopf HJ; Hardt WD; Benecke AG; Sirard JC
    Vaccine; 2015 Jun; 33(29):3331-41. PubMed ID: 26003491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TLR5 agonist inhibits acute renal ischemic failure.
    Fukuzawa N; Petro M; Baldwin WM; Gudkov AV; Fairchild RL
    J Immunol; 2011 Oct; 187(7):3831-9. PubMed ID: 21890657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model.
    Nguyen CT; Hong SH; Sin JI; Vu HV; Jeong K; Cho KO; Uematsu S; Akira S; Lee SE; Rhee JH
    Vaccine; 2013 Aug; 31(37):3879-87. PubMed ID: 23831323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.